Apr 1 |
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M
|
Mar 26 |
SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE DATE
|
Mar 25 |
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.
|
Mar 15 |
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million
|
Mar 5 |
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study
|
Mar 5 |
Summit Hotel Properties Offers 7.4% On Its Preferred Shares
|
Mar 1 |
Summit Hotel Properties, Inc. (NYSE:INN) Q4 2023 Earnings Call Transcript
|
Mar 1 |
Q4 2023 Summit Hotel Properties Inc Earnings Call
|
Feb 29 |
Summit Hotel Properties, Inc. (INN) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Summit Hotel Properties (INN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|